| Dr Syeda R Shergill, MD | |
|
559 Miller Ave, Clairton, PA 15025-1746 | |
| (412) 226-5454 | |
| Not Available |
| Full Name | Dr Syeda R Shergill |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 29 Years |
| Location | 559 Miller Ave, Clairton, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952381345 | NPI | - | NPPES |
| 1008548400005 | Medicaid | PA | |
| 1008548400002 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD419791 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Heritage Valley Beaver | Beaver, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Heritage Valley Multispecialty Group Inc | 0042105678 | 235 |
| Cornerstone Care Inc. | 7911811583 | 17 |
News Archive
Didac Martí et al., from the Polytechnic University of Catalonia, in a recent bioRxiv preprint research paper, explore the effect of the temperature on the molecular structure of the SARS-CoV-2 spike glycoprotein. The study specifically focuses on the spike glycoprotein's molecular structural integrity at different temperatures (within 25 ºC and 100 ºC) using atomistic computer simulations.
Researchers at Children's Hospital Boston and Brigham and Women's Hospital have received funding from the National Heart, Lung, and Blood Institute (NHLBI) to support their search for undiscovered gene defects that cause congenital heart disease. The $4.19 million, 6-year grant is part of the Pediatric Cardiac Genomics Consortium (PCGC), which seeks to identify genetic and epigenetic causes of human congenital heart disease, and relate genetic variants present in the congenital heart disease patient population to clinical outcomes.
Walgreen Co. of Deerfield, Ill., has agreed to pay $35 million to settle claims that from 2001 to 2005, it improperly switched patients to different versions of the prescriptions drugs Ranitidine, Fluoxetine and Eldepryl in order to increase its reimbursement from Medicaid, the Justice Department announced today.
Soot and dust alters thyroid development in fetuses before they are born in smoggy cities, raising concern about health impacts later in life, new USC research shows.
Octapharma USA today announced the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) has awarded seven years of marketing exclusivity for Octagam® 10% [Immune Globulin Intravenous (Human)], the first and only intravenous immunoglobulin (IVIg) to be indicated for the treatment of adult dermatomyositis (DM).
› Verified 2 days ago
| Entity Name | Cornerstone Care Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376512582 PECOS PAC ID: 7911811583 Enrollment ID: O20031118000237 |
News Archive
Didac Martí et al., from the Polytechnic University of Catalonia, in a recent bioRxiv preprint research paper, explore the effect of the temperature on the molecular structure of the SARS-CoV-2 spike glycoprotein. The study specifically focuses on the spike glycoprotein's molecular structural integrity at different temperatures (within 25 ºC and 100 ºC) using atomistic computer simulations.
Researchers at Children's Hospital Boston and Brigham and Women's Hospital have received funding from the National Heart, Lung, and Blood Institute (NHLBI) to support their search for undiscovered gene defects that cause congenital heart disease. The $4.19 million, 6-year grant is part of the Pediatric Cardiac Genomics Consortium (PCGC), which seeks to identify genetic and epigenetic causes of human congenital heart disease, and relate genetic variants present in the congenital heart disease patient population to clinical outcomes.
Walgreen Co. of Deerfield, Ill., has agreed to pay $35 million to settle claims that from 2001 to 2005, it improperly switched patients to different versions of the prescriptions drugs Ranitidine, Fluoxetine and Eldepryl in order to increase its reimbursement from Medicaid, the Justice Department announced today.
Soot and dust alters thyroid development in fetuses before they are born in smoggy cities, raising concern about health impacts later in life, new USC research shows.
Octapharma USA today announced the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) has awarded seven years of marketing exclusivity for Octagam® 10% [Immune Globulin Intravenous (Human)], the first and only intravenous immunoglobulin (IVIg) to be indicated for the treatment of adult dermatomyositis (DM).
› Verified 2 days ago
| Entity Name | Heritage Valley Multispecialty Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528015401 PECOS PAC ID: 0042105678 Enrollment ID: O20040220000870 |
News Archive
Didac Martí et al., from the Polytechnic University of Catalonia, in a recent bioRxiv preprint research paper, explore the effect of the temperature on the molecular structure of the SARS-CoV-2 spike glycoprotein. The study specifically focuses on the spike glycoprotein's molecular structural integrity at different temperatures (within 25 ºC and 100 ºC) using atomistic computer simulations.
Researchers at Children's Hospital Boston and Brigham and Women's Hospital have received funding from the National Heart, Lung, and Blood Institute (NHLBI) to support their search for undiscovered gene defects that cause congenital heart disease. The $4.19 million, 6-year grant is part of the Pediatric Cardiac Genomics Consortium (PCGC), which seeks to identify genetic and epigenetic causes of human congenital heart disease, and relate genetic variants present in the congenital heart disease patient population to clinical outcomes.
Walgreen Co. of Deerfield, Ill., has agreed to pay $35 million to settle claims that from 2001 to 2005, it improperly switched patients to different versions of the prescriptions drugs Ranitidine, Fluoxetine and Eldepryl in order to increase its reimbursement from Medicaid, the Justice Department announced today.
Soot and dust alters thyroid development in fetuses before they are born in smoggy cities, raising concern about health impacts later in life, new USC research shows.
Octapharma USA today announced the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) has awarded seven years of marketing exclusivity for Octagam® 10% [Immune Globulin Intravenous (Human)], the first and only intravenous immunoglobulin (IVIg) to be indicated for the treatment of adult dermatomyositis (DM).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Syeda R Shergill, MD 835 Hospital Rd, Indiana, PA 15701-3629 Ph: (724) 357-7493 | Dr Syeda R Shergill, MD 559 Miller Ave, Clairton, PA 15025-1746 Ph: (412) 226-5454 |
News Archive
Didac Martí et al., from the Polytechnic University of Catalonia, in a recent bioRxiv preprint research paper, explore the effect of the temperature on the molecular structure of the SARS-CoV-2 spike glycoprotein. The study specifically focuses on the spike glycoprotein's molecular structural integrity at different temperatures (within 25 ºC and 100 ºC) using atomistic computer simulations.
Researchers at Children's Hospital Boston and Brigham and Women's Hospital have received funding from the National Heart, Lung, and Blood Institute (NHLBI) to support their search for undiscovered gene defects that cause congenital heart disease. The $4.19 million, 6-year grant is part of the Pediatric Cardiac Genomics Consortium (PCGC), which seeks to identify genetic and epigenetic causes of human congenital heart disease, and relate genetic variants present in the congenital heart disease patient population to clinical outcomes.
Walgreen Co. of Deerfield, Ill., has agreed to pay $35 million to settle claims that from 2001 to 2005, it improperly switched patients to different versions of the prescriptions drugs Ranitidine, Fluoxetine and Eldepryl in order to increase its reimbursement from Medicaid, the Justice Department announced today.
Soot and dust alters thyroid development in fetuses before they are born in smoggy cities, raising concern about health impacts later in life, new USC research shows.
Octapharma USA today announced the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) has awarded seven years of marketing exclusivity for Octagam® 10% [Immune Globulin Intravenous (Human)], the first and only intravenous immunoglobulin (IVIg) to be indicated for the treatment of adult dermatomyositis (DM).
› Verified 2 days ago
Eduardo C Lu, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1200 Brooks Ln, Suite 270, Clairton, PA 15025 Phone: 412-469-7120 Fax: 412-469-7120 | |
Bruno Casile, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Brooks Ln Ste 110, Clairton, PA 15025 Phone: 412-466-5502 Fax: 412-469-8948 | |
Dr. Matthew Gary Walton, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Brooks Ln Ste 110, Clairton, PA 15025 Phone: 412-466-5502 Fax: 412-469-8948 |